Refine by
Patient Simulator Articles & Analysis
15 news found
The company's core mission is to increase human life expectancy through artificial intelligence-driven biosystem simulations and to personalize patient treatment. VeriSIM Life provides insights to pharma, biotech, academia, and research institutions and conducts risk-sharing collaborations to develop promising drugs, paving the preclinical development roadmap ...
Cellworks Biosimulation Platform The Cellworks Biosimulation Platform simulates how a patient's personalized genomic disease model will respond to therapies prior to treatment. ...
“In contrast to population-based therapy guidelines, the Cellworks Biosimulation Platform produces personalized therapy predictions for each NSCLC patient based on a patient-specific multi-omic disease model. The myCare-203A study found that the personalized approach of Cellworks SingulaTM TRI produces a more precise therapeutic decision guide for ...
“Cellworks personalized therapy biosimulation enables us to utilize a patient’s comprehensive next generation sequencing (NGS) results and understand the downstream molecular effects of specific drugs on cell signaling to predict how each patient will respond to therapies prior to treatment. ...
“But by using a patient’s NGS data and Cellworks SingulaTM to biosimulate their individual therapy responses, we can potentially improve the ability to select the most effective therapy for each GBM patient and positively effect clinical outcomes for brain cancer ...
BOSTON & LJUBLJANA, Slovenia--(BUSINESS WIRE)--Neutron Therapeutics, a targeted radiation therapy company developing a comprehensive solution for Boron Neutron Capture Therapy (BNCT), and Cosylab, the world’s leading provider of control systems for the planet’s most complex machines, today announced that Neutron Therapeutics' nuBeam® BNCT System, using Cosylab's OncologyOne ...
Realists GmbH is a global provider of lifelike surgical training systems to improve patient outcomes in the field of spinal surgery. Realists has integrated the NDI Polaris Vicra into their Realists Imaging product to simulate X-ray imaging for the navigation and placement of pedicle screws or cages, as in a real operation. ...
The teams will collaborate to develop several case-specific 3D-printed models of mitral and aortic valves that they will use to simulate patient-specific procedures ahead of the real-life case to validate the training solution. ...
ByBIOMODEX
” The Cellworks Biosimulation Platform simulates how a patient's personalized genomic disease model will respond to therapies prior to treatment and identifies novel drug combinations for treatment-refractory patients. ...
The study found that Cellworks biosimulation identifies novel biomarkers that predict therapy response in AML patients, which offers the opportunity to tailor FDA-approved chemotherapy regimens to each patient to improve disease control and minimize toxicity. ...
“There is a need for a predictive clinical approach that can stratify MDS patients according to their chance of a favorable outcome from current therapies, while also identifying and predicting their responses to new and emerging treatment options,” said Dr. ...
BIOMODEX, the leader in bio-realistic haptic simulators for patient-specific rehearsal and physician training, today announced that its LAACS (Left Atrial Appendage Closure System) solution was used to perform a simulation ahead of a live case to be presented at the TVT Structural Heart Summit in Miami, FL. ...
ByBIOMODEX
Novadiscovery (“NOVA”), a leading health tech company offering JINKO, a best-in-class clinical trial simulation platform to predict drug efficacy and optimize clinical trial development, today announces that it has entered into a new collaboration with “Takeda Pharmaceutical Company Limited (“Takeda”) aimed at incorporating clinical ...
Novadiscovery, a leading health tech company offering a best-in-class clinical trial simulation platform, Jinko®, to predict drug efficacy and optimize clinical trial development, today announces that it has entered into a collaboration with Janssen France to provide in silico based decision support for its clinical development pipeline. Novadiscovery is committed to working ...
While new, VeraForm has already been placed in thousands of breast cancer patients to mark the lumpectomy tumor bed cavity. William Chou, M.D., led the effort for radiation oncology, as this patient subsequently received image planning and radiation therapy. ...